Bellevue Group Ag Davita Inc. Transaction History

Bellevue Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.2 - $108.8 $278,160 - $413,440	3,800 New	3,800 $398,000
Q2 2021 Aug 12, 2021	SELL	$105.44 - $127.98 $38.8 Million - $47 Million	-367,600 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$99.98 - $123.89 $1.44 Million - $1.78 Million	14,400 Added 4.08%	367,600 $39.6 Million
Q4 2020 Feb 16, 2021	BUY	$82.82 - $117.4 $2.22 Million - $3.15 Million	26,800 Added 8.21%	353,200 $41.5 Million
Q3 2020 Nov 16, 2020	BUY	$79.57 - $91.84 $2.08 Million - $2.41 Million	26,200 Added 8.73%	326,400 $28 Million
Q2 2020 Aug 13, 2020	BUY	$65.52 - $88.28 $19.7 Million - $26.5 Million	300,200 New	300,200 $23.8 Million
Q3 2017 Nov 13, 2017	SELL	$56.13 - $64.78 $561,300 - $647,800	-10,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	10,000	10,000 $648,000

663

74.4M

1.41M

1.82M

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $13.5B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.